SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-048401
Filing Date
2020-04-20
Accepted
2020-04-20 06:07:58
Documents
5
Period of Report
2020-06-12
Effectiveness Date
2020-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm202108-1_def14a.htm DEF 14A 498388
2 GRAPHIC lg_mersana.jpg GRAPHIC 89308
3 GRAPHIC sg_protopapas.jpg GRAPHIC 81893
4 GRAPHIC tm202108-1_pc1.jpg GRAPHIC 476276
5 GRAPHIC tm202108-1_pc2.jpg GRAPHIC 427390
  Complete submission text file 0001104659-20-048401.txt   1976605
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38129 | Film No.: 20801160
SIC: 2834 Pharmaceutical Preparations